Lead sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

6 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

6

Trials led

3

Active

237

Total enrollment

4

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2/3
4
Phase 3
1
Not applicable
1

Trials by status

Recruiting
3
Completed
2
Unknown
1

Trials led

TZPBMI ≥27Ph 2/3Recruiting105
SEMPABMI ≥23Ph 3Recruiting36
FCLPh 2/3Unknown30
SEMA-APHbA1c ≤11%Ph 2/3Completed28
SEMA SMAPh 2/3Recruiting26
FCLnot applicableCompleted12